Article Information
History
- December 21, 2022.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jasmin Kazenwadel1,
- Georgy Berezhnoy1,
- Claire Cannet2,
- Hartmut Schäfer2,
- Tobias Geisler3,
- Anne-Katrin Rohlfing3,
- Meinrad Gawaz3,
- Uta Merle4,† and
- Christoph Trautwein1,*,†
- 1Werner Siemens Imaging Center, Department for Preclinical Imaging and Radiopharmacy, Eberhard Karls University Tuebingen, Germany
- 2Bruker BioSpin GmbH, Applied Industrial and Clinical Division, Ettlingen, Germany
- 3Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, Tübingen, Germany
- 4Department of Internal Medicine IV, University Hospital Heidelberg, Heidelberg, Germany
- ↵*Author to whom correspondence should be addressed: Christoph.Trautwein{at}med.uni-tuebingen.de
↵† These authors contributed equally to this work.
Posted December 21, 2022.
Stratification of hypertensive COVID-19 patients by quantitative NMR spectroscopy of serum metabolites, lipoproteins and inflammation markers
